High-affinity IgE receptor (FcepsilonRI)-mediated mast cell activation is thought to be critical to the pathogenesis of asthma and other allergic diseases and the host defense against certain parasites. Recently, we have found that mouse mast cell survival and growth are promoted by monomeric IgE binding to FcepsilonRI. Monomeric IgE does not promote DNA synthesis but suppresses the apoptosis induced by growth factor deprivation. This anti-apoptotic effect occurs in parallel with IgE-induced increases in FcepsilonRI surface expression but requires the continuous presence of IgE. These and other data have led us to hypothesize that monomeric IgE binding to FcepsilonRI promotes mast cell growth by suppressing apoptosis. The signal generated by monomeric IgE binding is distinctly different from those generated by FcepsilonRI cross-linking. The anti-apoptotic process initiated by IgE-bound FcepsilonRI involves accelerated degradation of p75NTR, a pro-apoptotic low-affinity receptor for nerve growth factor and other neurotrophins. In order to expand this hypothesis, 1) we will investigate the in vitro effects of monomeric IgE on the growth and survival of rodent and human mast cells and basophils. In light of our data that IgE on the growth facilitates in vitro differentiation of mouse mast cells, we will investigate the IgE effects on the phenotype and functionality of mast cells generated in the presence of IgE. 2) We will analyze the molecular mechanisms by which monomeric IgE interferes with p75NTR-mediated signaling events during the apoptotic process induced by growth factor deprivation in mast cells. To extend our in vitro observations to in vivo studies, 3) we will investigate in vivo effects of IgE on mast cell/basophil growth and survival. These proposed studies are expected not only to shed novel insight into the IgE-dependent process of mast cell biology but also to provide a theoretical basis for the therapeutic approaches aimed at reducing circulating IgE using anti-IgE mAb or soluble FcepsilonRIalpha to the treatment of asthma and other allergic diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI050209-03
Application #
6755988
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Plaut, Marshall
Project Start
2002-06-01
Project End
2007-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
3
Fiscal Year
2004
Total Cost
$514,072
Indirect Cost
Name
La Jolla Institute
Department
Type
DUNS #
603880287
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Ando, Tomoaki; Matsumoto, Kenji; Namiranian, Siavash et al. (2015) Mast Cells Are Required for Full Expression of Allergen/SEB-Induced Skin Inflammation. J Invest Dermatol 135:925
Ando, Tomoaki; Xiao, Wenbin; Gao, Peisong et al. (2014) Critical role for mast cell Stat5 activity in skin inflammation. Cell Rep 6:366-76
Kawakami, Toshiaki; Xiao, Wenbin (2013) Phospholipase C-? in immune cells. Adv Biol Regul 53:249-57
Ando, Tomoaki; Matsumoto, Kenji; Namiranian, Siavash et al. (2013) Mast cells are required for full expression of allergen/SEB-induced skin inflammation. J Invest Dermatol 133:2695-2705
Xiao, Wenbin; Kashiwakura, Jun-Ichi; Hong, Hong et al. (2011) Phospholipase C-?3 regulates Fc?RI-mediated mast cell activation by recruiting the protein phosphatase SHP-1. Immunity 34:893-904
Poderycki, Michael; Tomimori, Yoshiaki; Ando, Tomoaki et al. (2010) A minor catalytic activity of Src family kinases is sufficient for maximal activation of mast cells via the high-affinity IgE receptor. J Immunol 184:84-93
Kashiwakura, Jun-ichi; Kawakami, Yuko; Yuki, Keisuke et al. (2009) Polyclonal IgE induces mast cell survival and cytokine production. Allergol Int 58:411-9
Xiao, Wenbin; Hong, Hong; Kawakami, Yuko et al. (2009) Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. Cancer Cell 16:161-71
Kashiwakura, Jun-ichi; Xiao, Wenbin; Kitaura, Jiro et al. (2008) Pivotal advance: IgE accelerates in vitro development of mast cells and modifies their phenotype. J Leukoc Biol 84:357-67
Hong, Hong; Kitaura, Jiro; Xiao, Wenbin et al. (2007) The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. Blood 110:2511-9

Showing the most recent 10 out of 22 publications